630 PD-L1/CD47 tumor directed B-BodyTM bispecific antibodies demonstrating significant anti-tumor activity with no toxicity in preclinical models

by Peter Lamb, Seema Kantak, Bryan Glaser, Justin Wetter, Bee-Cheng Sim, Jeff Higaki, Jacob Beal, Sara Ollerman, Dileep Pulukkunat, Mandar Bawadekar, Charles Kaplan, Bonnie Hammer
Published 2020-11-01